Verified#101554
PT-141
Advancing Research in Human Performance and Desire
$31 - $245Australia & New ZealandShips Australia, New Zealand
Verified Supplier#1015564XI5S41HDDX9
Retatrutide
Triple-Action Fat Burner with Unmatched Results · 10mg~30mg
MOQ: 1 vial
Wholesale Pricing$78 - $1768Supplier marketplace pricing range
Purity99.363%
Tested23 JAN 2026
Supplier Rating★ 4.9
Orders184
Verified supplierAustralia & New Zealand
Vital Edge ScienceAustralia and New Zealand peptide research supplier operating NSW and New Zealand fulfilment warehouses with fast domestic dispatch, verified peptide research compounds, tracked express delivery, and public batch verification support for research customers.
Australia Post ExpressNZ CourierPostTracked Express Delivery
Supplier listing intelligence
Retatrutide wholesale supplier listing
Product overview
<p> Retatrutide is a next-generation peptide engineered to target three major metabolic receptors — GIP, GLP-1, and glucagon — supporting advanced metabolic and body composition research. </p> <p> Public clinical investigations have demonstrated significant weight reduction potential, with trial participants reaching up to 17.5% body weight reduction within 24 weeks under controlled study conditions. </p> <p> Retatrutide research is commonly associated with appetite regulation, metabolic optimisation, insulin sensitivity pathways, and sustained fat metabolism analysis. </p> <p> This Vital Edge Science research batch features ultra-pure Retatrutide with 99.3%+ Janoshik-verified purity, supported by public batch verification and Australia/New Zealand fulfilment. </p> <p> Recommended for reconstitution using bacteriostatic water within a pH range of 5.7 to 7.0. </p> <p> Each vial contains 10mg~30mg of research-grade Retatrutide depending on selected variant. </p> <p> <strong>For research use only.</strong> </p>
Purity99.363%
MOQ1 vial
MG Range10mg~30mg
SupplierVital Edge Science
Supplier details
Vital Edge Science
CountryAustralia & New Zealand
Task Number#101556
Verification Key4XI5S41HDDX9
Tested23 JAN 2026
Global fulfilment
Shipping lanes
Tracking information is provided immediately after dispatch with live courier updates throughout transit.
Free Express Delivery Australia Wide1–3 business daysFree shipping
Free Express Delivery New Zealand1–2 business daysFree shipping
More from this seller
More products from Vital Edge Science
Browse additional verified listings from the same marketplace supplier.
Verified#84089
BPC-157
Your Body’s Healing Accelerator
$45 - $298Australia & New ZealandShips Australia, New Zealand
Verified#91588
MOTS-C
Next-Generation Peptide for Metabolic and Mitochondrial Support
$112 - $765Australia & New ZealandShips Australia, New Zealand
Verified#104552
TB-500 (TB4)
Enhance Recovery, Flexibility & Muscle Health
$77 - $504Australia & New ZealandShips Australia, New Zealand
Compound intelligence
Retatrutide
Overview
Retatrutide is an investigational synthetic peptide designed as a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways. It is one of the most closely watched metabolic research compounds because it combines three incretin and energy-balance signalling pathways in a single molecule.
Molecular Class
Synthetic peptide / incretin-based triple hormone receptor agonist.
Mechanism
Retatrutide is designed to activate glucose-dependent insulinotropic polypeptide receptor, glucagon-like peptide-1 receptor, and glucagon receptor pathways. This combined receptor profile makes it different from single GLP-1 agonists and dual GIP/GLP-1 agonists.
Research Areas
- Obesity research
- Metabolic signalling research
- Type 2 diabetes research
- Liver-fat and MASLD research
- Appetite and satiety pathway research
- Cardiovascular risk-factor research
- Energy expenditure research
- Incretin pharmacology research
Research Status
Retatrutide remains an investigational compound in active clinical development. Lilly is studying it across several Phase 3 programs, including obesity, type 2 diabetes, sleep apnea, osteoarthritis, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease.
Market Demand
Global demand is driven by obesity, metabolic disease, GLP-1, and next-generation incretin research. China-based peptide manufacturers frequently list retatrutide in wholesale vial formats for international research buyers.
Product FAQ
Retatrutide supplier questions
What is Retatrutide?
Retatrutide is a triple-action fat burner with unmatched results supplied by Vital Edge Science, featuring public Janoshik-linked batch testing references, 10mg~30mg vial configurations, and Australia & New Zealand fulfilment support for research-use laboratory workflows.
What MG configurations are available for Retatrutide?
Retatrutide is available in 10mg~30mg configurations depending on Vital Edge Science inventory availability and supplier stock levels.
Has Retatrutide undergone batch testing?
Vital Edge Science is a peptide supplier operating from Australia & New Zealand, offering Retatrutide batches with public laboratory testing references and international fulfilment support.
Who supplies this Retatrutide?
Vital Edge Science is a Australia & New Zealand-based peptide supplier offering Retatrutide batches with public laboratory testing references and international fulfilment support.
What is the MOQ for Retatrutide?
The current minimum order quantity for Retatrutide is 1 vial.
Is Retatrutide intended for human use?
Retatrutide is supplied strictly for laboratory research use only and is not sold for human consumption, medical use, or self-administration.